More stories

  • in

    Major global chip equipment makers’ China revenue share has doubled since U.S. imposed export controls

    Four of the world’s largest chip equipment manufacturers have more than doubled the share of their China revenue since late 2022, Bank of America analysts said.
    “China accelerated its purchase of semi manufacturing equipment since the U.S. imposed tighter export restrictions in October 2022, aiming to develop its own semi manufacturing capability,” the report said.
    The research found the companies’ China revenue more than doubled from 17% of total revenue in the fourth quarter of 2022 to 41% in the first quarter of 2024.

    A worker produces chips at a semiconductor manufacturing enterprise in Binzhou, China, on June 4, 2024.
    Nurphoto | Nurphoto | Getty Images

    BEIJING — Four of the world’s largest semiconductor equipment manufacturers, including ASML, have seen the share of their China revenue more than double since late 2022, Bank of America analysts said in a report Monday.
    “China accelerated its purchase of semi manufacturing equipment since the U.S. imposed tighter export restrictions in October 2022, aiming to develop its own semi manufacturing capability,” the report said.

    The BofA analysis looked at Lam Research, ASML, KLA Corp. and Applied Materials.
    The research found the companies’ China revenue more than doubled from 17% of their total revenue in the fourth quarter of 2022 to 41% in the first quarter of 2024.
    “Tech, especially semi, is at the center stage of trade tensions with China, which could be more at risk if tensions further escalate from here,” the report said.
    The U.S. in October 2022 started imposing sweeping export controls on U.S. sales of advanced semiconductors and related manufacturing equipment to China. Last week, Bloomberg reported, citing sources, that the Biden administration was considering broader restrictions on semiconductor equipment exports to China that could affect non-U.S. companies.
    Beijing, meanwhile, has sought to bolster its tech self-sufficiency, a goal top leaders reaffirmed at a key policy meeting last week.
    The VanEck Semiconductor ETF (SMH), which tracks U.S.-listed chip companies, has fallen in the last week but is still holding gains of nearly 46% for the year so far. More

  • in

    Stocks making the biggest moves after hours: Alphabet, Tesla, Visa and more

    A dog looks out the window from a Tesla electric vehicle charging at a Tesla Supercharger location in Santa Monica, California, on May 15, 2024.
    Patrick T. Fallon | AFP | Getty Images

    Check out the companies making headlines in extended trading:
    Alphabet — The tech giant slipped 1% despite a beat on both top and bottom lines in the second quarter. Alphabet earned $1.89 per share on $84.74 billion in revenue. Consensus estimates had called for earnings of $1.84 per share on $84.19 billion in revenue. However, revenue at its YouTube advertising segment missed forecasts.

    Tesla — Shares of the electric vehicle maker declined 4.7% after second-quarter earnings missed consensus estimates. Tesla reported adjusted earnings per share at 52 cents, while analysts surveyed by LSEG had called for 62 cents per share. On the other hand, the company posted $25.5 billion in quarterly revenue, which was slightly higher than the $24.77 billion estimated by the Street. 
    Visa — Shares slipped more than 2% after the company posted a revenue miss in its fiscal third quarter. Visa reported $8.9 billion in revenue, which came in slightly below the $8.92 billion forecast by analysts polled by LSEG. Meanwhile, payments volume rose 7% in the quarter. 
    Seagate — Shares rallied more than 6% after Seagate posted an earnings and revenue beat in the fiscal fourth quarter. Seagate earned $1.05 per share, excluding items, on $1.89 billion in revenue. Analysts surveyed by LSEG had estimated it would earn 75 cents per share on revenue of $1.87 billion. The company cited an improving cloud environment for its stronger performance.
    Capital One Financial — Shares of the credit card issuer fell about 1% after its second-quarter profit fell from a year ago as the bank put aside more money to offset potential credit losses. Revenue rose 5% to $9.51 billion from the year-ago period, but was lower than analysts surveyed by LSEG had expected.
    Texas Instruments — The chipmaker rallied 5% after reporting better-than-expected earnings. Texas Instruments recorded $1.22 in earnings per share versus the consensus estimate of $1.17 per share, per LSEG. The company’s revenue of $3.82 billion came in line with forecasts.

    Mattel — The toymaker advanced more than 1% after announcing its second-quarter results. Its adjusted earnings per share of 19 cents topped analysts’ estimates for 17 cents per share, according to LSEG data. Revenue of $1.08 billion slightly missed forecasts of $1.1 billion. Mattel reiterated its full-year guidance and highlighted its gross margin expansion.
    Cal-Maine Foods — Shares of the nation’s largest egg producer fell 1% as the avian flu outbreak continues to pressure its performance. In the fiscal fourth quarter, earnings of $2.32 per share were higher than a year ago, but shy of the $2.41 per share analysts predicted, according to FactSet. Sales of $640.8 million also fell short of the $652.3 million estimate.
    Enphase Energy — The solar energy stock added 5% despite weaker-than-expected second-quarter results. Enphase posted earnings of 43 cents per share, after adjustments, which was 5 cents below consensus estimates, according to LSEG. Revenue of $304 million also fell short of the $310 million analysts forecast. However, shares rose on better-than-expected margins and its third-quarter forecast of between $370 million and $410 million in revenue, which was above the $404 million analyst estimate.
    Chubb — The insurance company gained nearly 1%. Adjusted earnings per share came in at $5.38 in the second quarter, beating the consensus estimate of $5.14 per share, per FactSet. 
    — CNBC’s Christina Cheddar Berk contributed reporting. More

  • in

    Why is Xi Jinping building secret commodity stockpiles?

    Over the past two decades China has devoured enormous amounts of raw materials. Its population has grown bigger and richer, requiring more dairy, grain and meat. Its giant industries have been ravenous for energy and metals. In recent years, though, the economy has suffered from political mismanagement and a property crisis. Chinese officials are adamant that they want to shift away from resource-intensive industries. Logic dictates that the country’s appetite for commodities should be shrinking, and shrinking fast.In reality, the opposite is happening. Last year China’s imports of many basic resources broke records, and imports of all types of commodities surged by 16% in volume terms. They are still rising, up by 6% in the first five months of this year. Given the country’s economic struggles, this does not reflect growing consumption. Instead, China appears to be stockpiling materials at a rapid pace—and at a time when commodities are expensive. Policymakers in Beijing seem to be worried about new geopolitical threats, not least that a new, hawkish American president could seek to choke crucial supply routes to China. More

  • in

    June home sales slump, pointing to a buyer’s market as supply increases

    Sales of previously owned homes dropped 5.4% in June compared with May.
    Inventory jumped 23.4% from a year ago to 1.32 million units at the end of June, coming off record lows but still just a 4.1-month supply.
    The median price of an existing home sold in June was $426,900, an increase of 4.1% year over year

    A home is offered for sale on March 22, 2024 in Chicago, Illinois. 
    Scott Olson | Getty Images

    Sales of previously owned homes dropped 5.4% in June compared with May, to 3.89 million units on a seasonally adjusted, annualized basis, according to the National Association of Realtors. Sales were also 5.4% lower than June of last year. This is the slowest sales pace since December.
    These are closed sales, so based on contracts signed mostly in April and May, when the average rate on the 30-year fixed mortgage jumped above 7%. Rates have pulled back slightly since then, to the high 6% range.

    “We’re seeing a slow shift from a seller’s market to a buyer’s market,” said Lawrence Yun, chief economist for the Realtors. “Homes are sitting on the market a bit longer, and sellers are receiving fewer offers. More buyers are insisting on home inspections and appraisals, and inventory is definitively rising on a national basis.”
    Inventory jumped 23.4% from a year ago to 1.32 million units at the end of June, coming off record lows but still just a 4.1-month supply. A six-month supply is considered balanced between buyer and seller.
    These inventory levels are the highest supply since May 2020, boosted by homes sitting on the market longer. The average time that a home sat on the market was 22 days, up from 18 days a year ago.
    Even that new supply, however, is not helping ease prices. The median price of an existing home sold in June was $426,900, an increase of 4.1% year over year and an all-time high for the second straight month. Part of that is skewed because the higher end of the market is much stronger.
    Sales of homes priced over $1 million was the only price category seeing gains over last year, while the biggest drop in sales was in the $250,000 and lower range.

    Supply of homes for sale is weakest on the lower end, but is seeing a new surge now. While the sales price nationally is high, new listing prices are lower.
    “The median listing price is being held down by an influx in smaller and lower-priced listings. In fact, the number of for-sale homes in the $200k to $350k price bucket surged by 50% compared to a year ago,” said Danielle Hale, chief economist for Realtor.com.
    Higher-end buyers tend to use more cash, and 28% of sales were all cash, up from 26% a year ago. Investors pulled back a bit, though, making up 16% of sales, down from 18% one year ago.
    “Assuming more inventory continues to increase, two things would happen. Either home sales rise, or, if the prices do not rise, the prices would buckle down,” Yun added.

    Don’t miss these insights from CNBC PRO More

  • in

    GM slows its EV plans again even as sales grow

    GM is again slowing its plans for all-electric vehicles by further delaying a second U.S. electric truck plant and the Buick brand’s first EV.
    The delay also means the company will not achieve a prior target of having North American production capacity of 1 million EVs by 2025.
    GM did not update the timing on Buick’s first EV, which was expected in 2024.

    GM’s 2024 Chevrolet Equinox EV during a media launch event for the vehicle in Detroit, May 16, 2024.
    Michael Wayland / CNBC

    DETROIT – General Motors said Tuesday it is again slowing its plans for all-electric vehicles by further delaying a second U.S. electric truck plant and the Buick brand’s first EV.
    The six-month delay in retooling the electric truck plant in Michigan, until mid-2026, also means GM will not achieve a prior target of having North American production capacity of 1 million EVs by 2025.

    We are committed to growing responsibly and profitably,” GM CEO Mary Barra told investors Tuesday during the company’s second-quarter earnings call.
    Barra’s comments come a week after she raised concerns about GM hitting its North American EV production capacity target.
    Barra did not provide updated timing on Buick’s first EV, which was expected in 2024. The entire Buick brand has targeted being fully electric by 2030, as part of GM’s plans to exclusively offer consumer EVs by 2035.
    The changes add new questions about the Detroit automaker’s plans for future battery cell plants other than two current joint venture facilities with LG Energy Solution in North America. GM previously announced plans for four of the multibillion-dollar plants in the U.S. by 2026.
    Barra on Tuesday said the company would grow cell production in a “meaningful cadence.”

    GM CFO Paul Jacobson declined to discuss potential plans to delay or cancel the automaker’s future EV battery cell plants, aside from the two facilities making cells in Ohio and Tennessee.
    “We’re going to continue to be guided by the customer. We’re rapidly scaling in cell plants one and two,” Jacobson said during a media briefing. “We have nothing to comment on right now.”
    GM’s U.S. EV deliveries increased 40% during the second quarter compared with a year earlier to 21,930 units. Still, EVs made up only 3.2% of its total second-quarter U.S. sales.
    Jacobson said the company is set to ramp up assembly to achieve production and vehicle wholesales of between 200,000 and 250,000 all-electric vehicles in North America this year. He said the company wholesaled about 75,000 of its new EVs during the first half of the year.
    Jacobson reiterated GM expects its EVs to be profitable on a production, or contribution-margin basis, once it reaches output of 200,000 units by the fourth quarter.
    “We’re still holding to that,” Jacobson said, adding additional EV sales are expected to lower the company’s earnings, as they will be less than variable profits of GM’s traditional gas models

    Don’t miss these insights from CNBC PRO More

  • in

    Lawmakers introduce bipartisan bill aiming to crack down on drug middlemen as scrutiny ramps up

    Bipartisan lawmakers introduced a new bill that aims to crack down on the business practices of drug supply chain middlemen who allegedly inflate prescription medication prices in the U.S.
    The legislation aims to lower costs for patients enrolled in federal healthcare programs and ensure that community pharmacies are reimbursed fairly by so-called pharmacy benefit managers.
    It comes amid a House committee hearing featuring testimony by the three largest PBMs, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts.

    Feverpitched | Getty Images

    Bipartisan lawmakers introduced a new bill on Tuesday that aims to crack down on the business practices of drug supply chain middlemen who are widely accused of inflating prescription medication prices and harming U.S. patients and pharmacies.
    The legislation aims to ensure community pharmacies can provide care to patients enrolled in federal health-care programs while being reimbursed “fairly and transparently” by so-called pharmacy benefit managers, or PBMs. Under the “Pharmacists Fight Back Act,” seniors covered by Medicare and Medicaid, government employees and active duty service members, among other patients, would see lower health-care costs and have more freedom to choose which pharmacy to get their prescriptions from, according to a fact sheet on the bill.

    Reps. Jake Auchincloss, D-Mass., and Rep. Diana Harshbarger, R-Tenn., unveiled the bill ahead of a House Oversight and Accountability Committee hearing about the drug middlemen’s tactics on Tuesday. Executives of three of the largest PBMs – UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts – will testify on allegations that they play a role in rising healthcare costs, as federal scrutiny of their practices mounts. 
    The new bill joins dozens of other bipartisan efforts on the federal and state level to reform PBMs, which negotiate rebates with drug manufacturers on behalf of insurers, large employers and federal health plans. Those middlemen also create lists of medications, also known as formularies, that are covered by insurance and reimburse pharmacies for prescriptions. 
    But lawmakers and drugmakers alike argue that PBMs overcharge the plans they negotiate rebates for, underpay pharmacies and fail to pass on savings from those discounts to patients. Auchincloss said those practices have allowed PBMs to trap $300 billion in revenue in the middle of the drug supply chain between manufacturers and patients.
    Meanwhile, PBMs contend that drugmakers are responsible for setting high list prices for drugs, and argue that their tactics shield patients from high healthcare costs.
    Legislation targeting PBMs advanced through House and Senate committees with bipartisan support last year, and one proposal overwhelmingly passed the House in December. But that legislative momentum has stalled since Congress left PBM reform out of a massive government spending package earlier this year. 

    Meanwhile, the Biden administration has ramped up pressure on PBMs as Americans struggle to afford prescription drugs. The Federal Trade Commission is planning to sue Caremark, Express Scripts and OptumRx, CNBC previously reported. 

    Pedestrians walk by a CVS store on November in San Francisco, California.
    Justin Sullivan | Getty Images

    The new bill would do some of the same things as earlier legislation would, such as increasing transparency around certain PBM business practices and banning spread pricing, or charging plans more than what they pay pharmacies for a drug. 
    But Auchincloss, who co-led another PBM bill that passed the House last year, said his new legislation is “bigger and tougher,” and focuses on pharmacies. A Tuesday release about the bill also described it as the “most comprehensive PBM reform ever introduced at the federal level.”
    “It seeks to take the pharmacists’ view and say, ‘What is making it impossible for pharmacists to thrive as small business owners and provide clinical and pharmacological advice to the patients that they serve?'” Auchincloss told CNBC. “We’re systematically tackling the impediments to that mission …This bill is about those pharmacists fighting back against corporate greed.” 
    Auchincloss pointed to a new pharmacy reimbursement model under the bill, which would largely center around a medication’s so-called national average drug acquisition cost, or NADAC.  That measures the average price pharmacies pay to purchase a drug from manufacturers or wholesalers based on a survey of invoices. 
    “That is going to ensure that the actual cost of goods is what the price is predicated on,”, Auchincloss said. He added that the bill’s reimbursement model is most relevant to generic rather than branded prescription drugs. 
    Pharmacies are typically paid using a complicated system not directly based on what they spend to purchase medications. That model, which involves a multitiered network of insurers, manufacturers, PBMs and pharmacies, leads to ambiguity around fees and markups added to the original cost of a drug. 
    Among the bill’s other efforts, it requires PBMs to share 80% of rebates with patients and prohibits several other practices. It would bar requiring patients to obtain branded medications when a cheaper generic version is available, steering patients to PBM-affiliated pharmacies and excluding any in-network pharmacy from filling a prescription, among other tactics.
    The bill would “put in place much-needed reforms to stop the gouging of independent pharmacies, make life-saving drugs more affordable for patients, and implement solutions that will yield savings to taxpayers,” Harshbarger said in a statement. More

  • in

    A Silicon Valley executive had $400,000 stolen by cybercriminals while buying a home. Here’s her warning

    Rana Robillard, chief people officer at software startup Tekion, was tricked into sending her life savings to a criminal.
    What happened to Robillard, a 25-year veteran of tech companies, speaks to the increasingly sophisticated nature of cybercrime.
    Real estate, with its large transaction sizes and frequent use of wire transfers, has proven to be an especially lucrative target for criminals.

    Rana Robillard, an Oakland-based tech executive, in front of the home in Orinda, CA that she attempted to purchase earlier this year.
    Courtesy: Rana Robillard

    After a yearlong search, Rana Robillard was elated to learn she’d beaten three other bidders for a house in the leafy California suburb of Orinda, just outside of San Francisco.
    So when Robillard, chief people officer at software startup Tekion, received an email in late January from her mortgage broker with directions to wire a $398,359.58 down payment to a JPMorgan Chase account, she wasted no time sending the money.

    After all, the email appeared to be a response to one Robillard had sent her broker asking about final steps before the closing, which was rapidly approaching.
    But on Jan. 30, the day after she’d sent the wire, Robillard got what looked like a duplicate request for the down payment, and it dawned on her that she had fallen for a scam — one that would throw her life into turmoil for the next six months. To her horror, instead of sending a down payment for her future home to the title company, as she believed she had done, Robillard had been tricked into sending her life savings to a criminal.
    “That’s when I went into a full panic,” Robillard, 55, told CNBC, which verified the details of her story with the four banks involved.
    What happened to Robillard, a 25-year veteran of tech companies including cybersecurity firm HackerOne, speaks to the increasingly sophisticated nature of cybercrime. Fraudsters are able to penetrate the email systems of mortgage brokers, real estate agents, lawyers or other advisors, waiting for the perfect moment to strike by sending emails or phone calls that appear to be from trusted parties.
    Real estate, with its large transaction sizes and frequent use of wire transfers, has proven to be an especially lucrative target for criminals. Wires are faster than other forms of payment, typically closing within 24 hours, can handle far larger sums and are often irreversible, making them ideal for fraud.

    Scams involving fake emails in real estate deals have exploded over the last decade, rising from less than $9 million in losses in 2015 to $446.1 million by 2022, according to FBI data.

    Once criminals have a victim’s money, they quickly shuffle it to other bank accounts before withdrawing it as cash, converting it into crypto or exploiting mules to launder the funds, according to Naftali Harris, CEO of anti-fraud startup SentiLink. That’s why recovering funds in wire fraud can be so difficult, he added.
    “The faster the fraudster moves it out of that first account and the more institutions they move it to, the better for them, because it just gets murkier and harder to track,” Harris said.
    That’s what initially happened to Robillard’s funds, which went from a JPMorgan Chase account to ones at Citigroup and Ally Bank, according to people with knowledge of her case who weren’t authorized to speak publicly.
    Robillard had alerted her bank, Charles Schwab, of the fraud on Jan. 30; within days, an official working in the cyber branch of the San Francisco division of the FBI had this message:
    “Funds have been located and are frozen,” the official said, according to a Feb. 2 email reviewed by CNBC. “That’s all I’m allowed to tell you.”

    Waiting for months

    After that promising start, Robillard’s frustrations have only mounted.
    Robillard says she was initially told that her funds would likely be released after 90 days. But as the weeks and months stretched on, there were few updates from JPMorgan, which has taken the lead on the case, she said.
    The FBI told her that once the banks involved had frozen the funds, its role was over, she said. So Robillard became obsessed with advocating for herself, reaching out to elected officials and government agencies including the Federal Trade Commission and the Consumer Financial Protection Bureau.
    “Nobody will give you any updates or information,” Robillard said. “I’ve been very assertive trying to get people to help; every week I’m following up with random people on LinkedIn from Chase, I’m filing to the California attorney general, the FTC, the CFPB, but it’s gotten me nowhere.”
    In early July, Robillard told CNBC she had no idea whether she would ever see her money again.
    And while she’s been in financial limbo, the world has moved on. The home she had envisioned living in with her daughter — a newly renovated four bedroom on nearly half an acre of land — has been relisted by Opendoor for $1.63 million.

    Rana Robillard, an Oakland-based tech executive, in front of the home in Orinda, CA that she attempted to purchase earlier this year.
    Courtesy: Rana Robillard

    Robillard says she decided to publicize her story to boost awareness of real estate wire fraud, besides being a last-ditch attempt at getting her money back.
    “This is not what I thought my public representation would look like, which is that I’ve lost all this money,” Robillard said. “If it helps other people, I’m happy to do it, even though it’s obviously not my proudest moment.”

    Room for improvement

    Robillard acknowledges that she could’ve been more cautious before initiating the wire transfer. For one, she says she should’ve confirmed with OS National, the title company owned by Opendoor, that the wire request sent to her in January was an authentic one.
    But Robillard also sees ample room for improvement in all the parties involved: Her real estate agent should’ve explained that wire directions would be coming directly from the title company; the banks should’ve verified that the receiving account was that of a genuine title company and not a fraudster; and her mortgage broker should’ve used a secure portal for document sharing.
    In a chain of more than 20 emails seen by CNBC between Robillard and her mortgage processor, Kristy Aichinger of Compass Mortgage Advisors, just one was sent by the cybercriminal. It was indistinguishable from the rest.
    While Martinez, California-based Compass Mortgage denies being hacked, it acknowledged that the email with wire directions wasn’t from them, according to Robillard.
    When reached by phone last week, Aichinger declined to comment and referred a reporter to the company’s founder and president, Kent Donahue.
    Donahue didn’t respond to several detailed messages about this story.

    ‘We are sorry’

    After more than five months in limbo, Robillard finally caught a break.
    A few days after CNBC contacted the banks in early July about the Robillard case, she received a $150,000 wire from Chase, funds that had been bounced back from Ally. Then, on Thursday, Robillard got the balance of her down payment that had been at Citi, nearly $250,000.
    A JPMorgan spokesman had the following comment:
    “We are sorry to hear that Ms. Robillard was tricked into sending funds from her real estate transaction to an imposter,” the spokesman said. “Although she’s not our customer, we were able to recover all of her funds.”
    Further, JPMorgan said that consumers should be wary of last-minute changes to payment instructions and to always verify wire recipients before sending money.
    Robillard’s bank, Schwab, told CNBC that it urged customers to “remain vigilant in protecting their personal information, and stay skeptical when it comes to financial transactions.”
    Robillard still doesn’t know who was behind the scam.
    While overjoyed that she can finally begin a new home search, the tech executive struck a pessimistic note.
    The real estate industry has gotten used to closing transactions electronically, which is efficient, but leaves buyers open to fraud, she said. Advances in artificial intelligence will give criminals more tools to impersonate those they trust to steal Americans’ money, she warned.
    “The banks and real estate companies weren’t even prepared for the old world, how are they going to handle the new one?” Robillard said. “Nobody’s ready for what’s coming.” More

  • in

    GM far exceeds second-quarter estimates, will restructure struggling China business

    General Motors is raising several key financial targets for 2024 after easily beating Wall Street’s earnings expectations for the second quarter.
    Wall Street analysts expected adjusted earnings per share of $2.75 and revenue of $45.46 billion.
    GM executives will host an earnings conference call at 8:30 a.m. ET.

    DETROIT — General Motors is raising several key financial targets for 2024 after easily beating Wall Street’s earnings expectations for the second quarter, while it restructures money-losing operations such as autonomous vehicles and its China business.
    The Detroit automaker now expects full-year adjusted earnings before interest and taxes of between $13 billion and $15 billion, or $9.50 and $10.50, up from previous guidance of $12.5 billion to $14.5 billion, or $9 and $10, previously. It also raised its adjusted automotive free cash flow forecast, while slightly lowering the range for its net income attributable to stockholders by less than 1%.

    Here’s how the company performed in the second quarter, compared with average estimates compiled by LSEG:

    Earnings per share: $3.06 adjusted vs. $2.75 expected
    Revenue: $47.97 billion vs. $45.46 billion expected

    Shares of GM were up about 4% during premarket trading. The stock has risen roughly 38% in 2024.
    GM’s second-quarter results included net income attributable to stockholders, which excludes some dividend payouts, of $2.93 billion, up 14.3% from $2.57 billion a year earlier. On a per-share basis, GM reported earnings of $2.55, up from $1.83 a year earlier. Adjusted earnings before interest and taxes came in at $4.44 billion, up 37.2%, and adjusted earnings per share were $3.06.
    Its unadjusted net income was $2.88 billion, up 14.8% from a year earlier. GM said its revenue for the second quarter was a fresh quarterly record for the automaker, up 7.2% compared with $44.75 billion a year earlier.

    Stock chart icon

    GM’s stock performance in 2024.

    “It was truly a great first half and second quarter, and we’re positioned to have a very strong year,” GM CFO Paul Jacobson said during a media briefing. “We expect to see some seasonally higher commodity costs, as well as some pricing headwinds that we’ve assumed in the second half of the year.”

    Alongside the strong earnings, GM on Tuesday said it is indefinitely pausing production of its Cruise Origin autonomous vehicle, triggering a $600 million special charge in the second quarter. It also said it’s attempting to restructure a joint venture in China with SAIC amid continuing losses, including a $104 million loss in equity income during the second quarter.

    North America leads

    As they have in recent years, GM’s North American operations, driven by truck sales, were largely responsible for the company’s second-quarter beat and guidance raise. Specifically, pricing on the vehicles has remained more resilient than GM anticipated at the beginning of the year, according to Jacobson.
    GM said its average transaction price during the second quarter was roughly $50,000, with incentives lower than the U.S. industry average.
    The North America division increased adjusted earnings during the quarter to $4.43 billion, up nearly 40% from a year earlier. The unit reported a profit margin of 10.9%, up 2.3 percentage points from a year earlier.
    While GM outperformed in several areas, it did not achieve an anticipated return to profitability in China, where the automaker has experienced significant declines in earnings.

    The automaker’s Chinese operations posted an equity loss of $104 million – its second consecutive quarterly loss after hitting a roughly 20-year low in 2023.
    “In China, we’ve been taking steps to reduce our inventories, align production to demand, and reduce our fixed costs, but it’s clear that the steps that we’ve taken, while significant, have not been enough,” Jacobson said during a media briefing. “We’re working closely with our JV partner to restructure the business, to make it profitable and sustainable, while ensuring that it doesn’t require incremental capital.”
    GM’s international operations, which include South Korea, Brazil and the Middle East, reported adjusted earnings of $50 million during the second quarter, down 78.8% from a year earlier. Its financing arm reported adjusted earnings of $822 million, up 7.3% from a year earlier.

    EVs

    GM continues to target production and vehicle wholesales of between 200,000 and 250,000 all-electric vehicles in North America, despite slower-than-expected adoption.
    Its EV deliveries during the quarter increased 40% compared with a year earlier to 21,930 units. Still, EVs made up only 3.2% of its total second-quarter U.S. sales.
    Jacobson reconfirmed that GM expects its EVs to be profitable on a production, or contribution-margin basis, once it reaches output of 200,000 units by the fourth quarter.

    GM’s 2024 Chevrolet Equinox EV during a media launch event for the vehicle in Detroit, May 16, 2024.
    Michael Wayland / CNBC

    “EVs are going to be an earning headwind as we scale, until we reach variable profits positive during the fourth quarter, then they should start to become a tail wind for EBIT,” he said.
    Jacobson declined to discuss potential plans to delay or cancel the automaker’s future EV battery cell production in North America, aside from two joint venture plants currently producing cells with LG Energy Solution in Ohio and Tennessee.
    “We’re going to continue to be guided by the customer. We’re rapidly scaling in cell plants one and two,” Jacobson said. “We have nothing to comment on right now.”
    Last week, GM CEO Mary Barra said the automaker’s goal of reaching EV production capacity of 1 million vehicles in North America by the end of 2025 was heavily in doubt.

    Don’t miss these insights from CNBC PRO More